These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 35719957)
1. High DNMT1 Expression in Stromal Fibroblasts Promotes Angiogenesis and Unfavorable Outcome in Locally Advanced Breast Cancer Patients. Al-Kharashi LA; Tulbah A; Arafah M; Eldali AM; Al-Tweigeri T; Aboussekhra A Front Oncol; 2022; 12():877219. PubMed ID: 35719957 [TBL] [Abstract][Full Text] [Related]
2. Eugenol modulates genomic methylation and inactivates breast cancer-associated fibroblasts through E2F1-dependent downregulation of DNMT1/DNMT3A. Al-Kharashi LA; Bakheet T; AlHarbi WA; Al-Moghrabi N; Aboussekhra A Mol Carcinog; 2021 Nov; 60(11):784-795. PubMed ID: 34473867 [TBL] [Abstract][Full Text] [Related]
3. High AUF1 level in stromal fibroblasts promotes carcinogenesis and chemoresistance and predicts unfavorable prognosis among locally advanced breast cancer patients. Al-Tweigeri T; AlRaouji NN; Tulbah A; Arafah M; Aboussekhra M; Al-Mohanna F; Gad AM; Eldali AM; Elhassan TA; Aboussekhra A Breast Cancer Res; 2022 Jul; 24(1):46. PubMed ID: 35821051 [TBL] [Abstract][Full Text] [Related]
4. Clinical and functional significance of tumor/stromal ATR expression in breast cancer patients. Al-Ansari MM; Al-Saif M; Arafah M; Eldali AM; Tulbah A; Al-Tweigeri T; Semlali A; Khabar KS; Aboussekhra A Breast Cancer Res; 2020 May; 22(1):49. PubMed ID: 32414408 [TBL] [Abstract][Full Text] [Related]
5. The DNA methyl-transferase protein DNMT1 enhances tumor-promoting properties of breast stromal fibroblasts. Al-Kharashi LA; Al-Mohanna FH; Tulbah A; Aboussekhra A Oncotarget; 2018 Jan; 9(2):2329-2343. PubMed ID: 29416775 [TBL] [Abstract][Full Text] [Related]
6. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs). De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803 [TBL] [Abstract][Full Text] [Related]
7. MiR-205/YAP1 in Activated Fibroblasts of Breast Tumor Promotes VEGF-independent Angiogenesis through STAT3 Signaling. Du YE; Tu G; Yang G; Li G; Yang D; Lang L; Xi L; Sun K; Chen Y; Shu K; Liao H; Liu M; Hou Y Theranostics; 2017; 7(16):3972-3988. PubMed ID: 29109792 [TBL] [Abstract][Full Text] [Related]
8. Ionizing radiation normalizes the features of active breast cancer stromal fibroblasts and suppresses their paracrine pro-carcinogenic effects. Aboussekhra A; Alraouji NN; Al-Mohanna FH; Al-Khalaf H Transl Oncol; 2023 Nov; 37():101780. PubMed ID: 37672859 [TBL] [Abstract][Full Text] [Related]
9. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs). Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144 [TBL] [Abstract][Full Text] [Related]
10. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment. De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519 [TBL] [Abstract][Full Text] [Related]
11. CHEK2 represses breast stromal fibroblasts and their paracrine tumor-promoting effects through suppressing SDF-1 and IL-6. Al-Rakan MA; Hendrayani SF; Aboussekhra A BMC Cancer; 2016 Aug; 16():575. PubMed ID: 27484185 [TBL] [Abstract][Full Text] [Related]
12. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway. Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089 [TBL] [Abstract][Full Text] [Related]
13. Chitinase 3-like 1 secreted from cancer-associated fibroblasts promotes tumor angiogenesis via interleukin-8 secretion in colorectal cancer. Watanabe K; Shiga K; Maeda A; Harata S; Yanagita T; Suzuki T; Ushigome H; Maeda Y; Hirokawa T; Ogawa R; Hara M; Takahashi H; Matsuo Y; Mitsui A; Kimura M; Takiguchi S Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34913066 [TBL] [Abstract][Full Text] [Related]
15. Tocilizumab suppresses the pro-carcinogenic effects of breast cancer-associated fibroblasts through inhibition of the STAT3/AUF1 pathway. Al-Jomah N; Al-Mohanna FH; Aboussekhra A Carcinogenesis; 2021 Dec; 42(12):1439-1448. PubMed ID: 34718441 [TBL] [Abstract][Full Text] [Related]
16. Patient-Derived Primary Cancer-Associated Fibroblasts Mediate Resistance to Anti-Angiogenic Drug in Ovarian Cancers. Sulaiman R; De P; Aske JC; Lin X; Dale A; Koirala N; Gaster K; Espaillat LR; Starks D; Dey N Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672620 [TBL] [Abstract][Full Text] [Related]
17. p16INK4A represses breast stromal fibroblasts migration/invasion and their VEGF-A-dependent promotion of angiogenesis through Akt inhibition. Al-Ansari MM; Hendrayani SF; Tulbah A; Al-Tweigeri T; Shehata AI; Aboussekhra A Neoplasia; 2012 Dec; 14(12):1269-77. PubMed ID: 23308058 [TBL] [Abstract][Full Text] [Related]
18. DNA methyltransferase 1/3a overexpression in sporadic breast cancer is associated with reduced expression of estrogen receptor-alpha/breast cancer susceptibility gene 1 and poor prognosis. Yu Z; Xiao Q; Zhao L; Ren J; Bai X; Sun M; Wu H; Liu X; Song Z; Yan Y; Mi X; Wang E; Jin F; Wei M Mol Carcinog; 2015 Sep; 54(9):707-19. PubMed ID: 24464625 [TBL] [Abstract][Full Text] [Related]
19. GPER in CAFs regulates hypoxia-driven breast cancer invasion in a CTGF-dependent manner. Ren J; Guo H; Wu H; Tian T; Dong D; Zhang Y; Sui Y; Zhang Y; Zhao D; Wang S; Li Z; Zhang X; Liu R; Qian J; Wei H; Jiang W; Liu Y; Li Y Oncol Rep; 2015 Apr; 33(4):1929-37. PubMed ID: 25647524 [TBL] [Abstract][Full Text] [Related]
20. DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer. Mutze K; Langer R; Schumacher F; Becker K; Ott K; Novotny A; Hapfelmeier A; Höfler H; Keller G Eur J Cancer; 2011 Aug; 47(12):1817-25. PubMed ID: 21458988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]